News

JSC Grindeks invested €1.87 million to expand finished dosage form packaging capacity

JSC Grindeks has invested €1.87 million in a new packaging line at JSC Tallinna Farmaatsiatehas. During its first eight months of operation, the line produced...

Learn more..

JSC Grindeks subsidiary Ltd Grindeks Kalceks in Lithuania receives “Strongest in Lithuania 2026” recognition

JSC Grindeks’ subsidiary in Lithuania Ltd Grindeks Kalceks has received the “Strongest in Lithuania 2026” (Stipriausi Lietuvoje) recognition, confirming the company’s financial stability, reliability and...

07/10/2026

JSC Grindeks Expands into the UK Market with First Topical Corticosteroid Product Registration

JSC Grindeks is pleased to announce a significant milestone in its product portfolio expansion: the successful registration of betamethasone valerate cream in the United Kingdom....

21/04/2026

Cardiologist and RSU Associate Professor Kārlis Trušinskis receives prestigious D. H. Grindel Award

On March 26, one of the most significant events in the Latvian healthcare sector, the ceremonial “Medical Excellence Awards” took place at the Splendid Palace...

30/03/2026

Grindeks Group introduces CDMO and out-licensing services

Over the last decade, Grindeks has been focusing on its own brand portfolio, but under the new CEO we are shifting our business development strategy....

02/12/2025

Jānis Romanovskis Appointed as CEO of JSC “Grindeks”

Changes have taken place in the Management Board of JSC Grindeks – Jānis Romanovskis has been appointed as the company’s Chairman of the Board. Romanovskis’...

12/08/2025

Strong growth and strengthened market positions in Europe during the first half of Grindeks final transformation year

Financial results for “Grindeks” show that in the first half of 2025 – the company’s final year of transformation – the Group has achieved significant...

06/08/2025

Global